92732 ⎘
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#2ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR
#3Adhesive composition
#4Methods of preparing cytotoxic benzodiazepine derivatives
#5CARBONIC ACID ADDUCTS
#6MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#7MODULATORS OF TMEM16A FOR TREATING RESPIRATORY DISEASE
#8Method For Preparing Hexahydrofuro-Furanol Derivative, Intermediate Thereof And Preparation Method Thereof
#9Compositions for the treatment of pulmonary fibrosis
#10Methods of preparing cytotoxic benzodiazepine derivatives
#11Synthetic nicotine composition
#12Modulators of Sestrin-GATOR2 interaction and uses thereof
#13Carbonic acid adducts
#14Methods of preparing cytotoxic benzodiazepine derivatives
#15Modulators of Sestrin-GATOR2 interaction and uses thereof
#16MODIFIED HISTONE DEACETYLASE INHIBITORS AND USES THEREOF
#17COSMETIC BASE INCLUDING AMIDE ALCOHOL ESTER, AND COSMETIC
#18Benzylamide compound, method for producing the same, and miticide
#19Compositions for the treatment of pulmonary fibrosis
#20Production of bitter principle derivatives
#21Fluorinated 4-(substituted amino)phenyl carbamate derivatives
#22Analgesic compounds
#23Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient
#24Modulators of sestrin-GATOR2 interaction and uses thereof
#25Organic compound and organic electroluminescent element comprising same
#26Substituted malonamides and their use as antibacterial drugs
#27Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient
#28Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient
#29Organoleptic compounds
#303-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
#31N-(5-arylamido-2-methylphenyl)-5-methylisooxazole-4-carboxamide deravative, pharmaceutical acceptable salt thereof, method for preparation therof and FMS kinase inhibitor comprising the same as anactive ingredient
#32Modulators of sestrin-GATOR2 interaction and uses thereof
#33Allenamide as an orthogonal handle for selective modification of cysteine in peptides and proteins
#34Processes for forming amide bonds and compositions related thereto
#35Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of Alzheimer's disease
#36Treatment of friedreich's ataxia using histone deacetylase inhibitors
#37TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS
#38Aryloxy phenoxy acrylic compound having HIF-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
#39Treatment of friedreich's ataxia using histone deacetylase inhibitors
#40Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
#41Catalyst composition and method for preparing amide using the same
#42Processes for forming amide bonds and compositions related thereto
#43Catalytic system for cross-coupling reactions
#44Method for producing organic compound and organic compound obtained by the method
#45Method for separating amide from amino acid ionic liquid
#46TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS
#47Crystalline ACAT inhibitor
#48Method for the production of optically active alpha alkyl carbonyl compounds
#49Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
#50Histone deacetylase inhibitors
#51Process for preparing secondary amides by carbonylation of a corresponding tertiary amine
#52Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
#53TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#54Compounds and compositions for delivering active agents
#55Method for decarboxylating C—C cross-linking of carboxylic acids with carbon electrophiles
#56Ligands for metals and improved metal-catalyzed processes based thereon
#57Invertible amphiphilic polymers
#58Amide initiators
#59Histone deacetylase inhibitors as therapeutics for neurological diseases
#60Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
#61N-substituted pyrazolyl carboxanilides
#62Process for the preparation of -substituted formamides
#63Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#64Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#65Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds
#66Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#67Crystalline ACAT inhibitor
#68Ligands for metals and improved metal-catalyzed processes based thereon
#69Tricyclic steroid hormone nuclear receptor modulators
#70One-pot reductive acetamidation of aryl nitro compounds
#71Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
#72Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
#73Method for preparing nitrogen-containing compounds
#74Method for preparing nitrogen-containing compounds
#75Method for preparing nitrogen-containing compounds